Literature DB >> 27670077

Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.

Yue Wu1, James Wood2, Gulam Khandaker3, Claire Waddington4, Thomas Snelling5.   

Abstract

An estimated 110,000 babies are born with congenital rubella syndrome (CRS) worldwide annually; a significant proportion of cases occur in Southeast Asia. Rubella vaccine programs have led to successful control of rubella and CRS, and even the elimination of disease in many countries. However, if vaccination is poorly implemented it might increase the number of women reaching childbearing age who remain susceptible to rubella and thereby paradoxically increase CRS. We used an age-structured transmission model to compare seven alternative vaccine strategies for their impact on reducing CRS disease burden in East Java, a setting which is yet to implement a rubella vaccine program. We also investigated the robustness of model predictions to variation in vaccine coverage and other key epidemiological factors. Without rubella vaccination, approximately 700 babies are estimated to be born with CRS in East Java every year at an incidence of 0.77 per 1000live births. This incidence could be reduced to 0.0045 per 1000 live births associated with 99.9% annual reduction in rubella infections after 20 years if the existing two doses of measles vaccine are substituted with two doses of measles plus rubella combination vaccine with the same coverage (87.8% of 9-month-old infants and 80% of 6-year-old children). By comparison a single dose of rubella vaccine will take longer to reduce the burden of rubella and CRS and will be less robust to lower vaccine coverage. While the findings of this study should be informative for settings similar to East Java, the conclusions are dependent on vaccine coverage which would need consideration before applying to all of Indonesia and elsewhere in Asia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Congenital rubella syndrome; Developing countries; Immunisation; Modelling; Rubella vaccine; South-East Asia

Mesh:

Substances:

Year:  2016        PMID: 27670077     DOI: 10.1016/j.vaccine.2016.09.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies.

Authors:  Nkengafac Villyen Motaze; Zinhle E Mthombothi; Olatunji Adetokunboh; C Marijn Hazelbag; Enrique M Saldarriaga; Lawrence Mbuagbaw; Charles Shey Wiysonge
Journal:  Vaccines (Basel)       Date:  2021-01-25

2.  Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.

Authors:  Masaya M Saito; Keisuke Ejima; Ryo Kinoshita; Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2018-03-22       Impact factor: 3.390

3.  Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.

Authors:  Yitayih Wondimeneh; Moges Tiruneh; Getachew Ferede; Kassahun Denekew; Fisseha Admassu; Belay Tessema
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.